摩熵化学
数据库官网
小程序
打开微信扫一扫
首页 分子通 化学资讯 化学百科 反应查询 关于我们
请输入关键词

钾(2-甲氧基乙基)三氟硼酸酯 | 1408168-69-3

中文名称
钾(2-甲氧基乙基)三氟硼酸酯
中文别名
(2-甲氧乙基)三氟硼酸钾
英文名称
potassium trifluoro(2-methoxyethyl)borate
英文别名
Potassium (2-methoxyethyl)trifluoroborate;potassium;trifluoro(2-methoxyethyl)boranuide
钾(2-甲氧基乙基)三氟硼酸酯化学式
CAS
1408168-69-3
化学式
C3H7BF3O*K
mdl
MFCD18861717
分子量
165.992
InChiKey
DGWPDVMILPSZOB-UHFFFAOYSA-N
BEILSTEIN
——
EINECS
——
  • 物化性质
  • 计算性质
  • ADMET
  • 安全信息
  • SDS
  • 制备方法与用途
  • 上下游信息
  • 反应信息
  • 文献信息
  • 表征谱图
  • 同类化合物
  • 相关功能分类
  • 相关结构分类

计算性质

  • 辛醇/水分配系数(LogP):
    0.34
  • 重原子数:
    9
  • 可旋转键数:
    2
  • 环数:
    0.0
  • sp3杂化的碳原子比例:
    1.0
  • 拓扑面积:
    9.2
  • 氢给体数:
    0
  • 氢受体数:
    5

反应信息

  • 作为反应物:
    描述:
    参考文献:
    名称:
    Suzuki–Miyaura Cross-Coupling of Potassium Alkoxyethyltrifluoroborates: Access to Aryl/Heteroarylethyloxy Motifs
    摘要:
    The introduction of an alkoxyethyl moiety onto aromatic substructures has remained a long-standing challenge for synthetic organic chemists. The main reasons are the inherent instability of alkoxyethylmetallic species and the lack of general procedures to access them. A new method utilizing a cross-coupling strategy based on the exceptional properties of organotrifluoroborates has been developed, and the method allows an easy and efficient installation of this unit on a broad range of aryl and heteroaryl bromides.
    DOI:
    10.1021/jo3021665
  • 作为产物:
    描述:
    potassium hydrogen difluoride 、 2-(2-methoxyethyl)-4,4,5,5-tetramethyl-1,3,2-dioxaborolane四氢呋喃 为溶剂, 反应 2.0h, 以68%的产率得到钾(2-甲氧基乙基)三氟硼酸酯
    参考文献:
    名称:
    Suzuki–Miyaura Cross-Coupling of Potassium Alkoxyethyltrifluoroborates: Access to Aryl/Heteroarylethyloxy Motifs
    摘要:
    The introduction of an alkoxyethyl moiety onto aromatic substructures has remained a long-standing challenge for synthetic organic chemists. The main reasons are the inherent instability of alkoxyethylmetallic species and the lack of general procedures to access them. A new method utilizing a cross-coupling strategy based on the exceptional properties of organotrifluoroborates has been developed, and the method allows an easy and efficient installation of this unit on a broad range of aryl and heteroaryl bromides.
    DOI:
    10.1021/jo3021665
点击查看最新优质反应信息

文献信息

  • [EN] COMBINATION PHARMACEUTICAL AGENTS AS RSV INHIBITORS<br/>[FR] AGENTS PHARMACEUTIQUES EN COMBINAISON EN TANT QU'INHIBITEURS DE RSV
    申请人:ENANTA PHARM INC
    公开号:WO2019067864A1
    公开(公告)日:2019-04-04
    The present invention relates to pharmaceutical agents administered to a subject either in combination or in series for the treatment of a Respiratory Syncytial Virus (RSV) infection, wherein treatment comprises administering a compound effective to inhibit the function of the RSV and an additional compound or combinations of compounds having anti-RSV activity.
    本发明涉及用于治疗呼吸道合胞病毒(RSV)感染的药物剂,该药物剂可以单独或连续给予受试者,治疗包括给予一种有效抑制RSV功能的化合物以及具有抗RSV活性的另一种化合物或化合物组合。
  • [EN] BENZODIAZEPINE DERIVATIVES AS RSV INHIBITORS<br/>[FR] DÉRIVÉS BENZODIAZÉPINE UTILISÉS COMME INHIBITEURS DU VIRUS RESPIRATOIRE SYNCYTIAL (RSV)
    申请人:ENANTA PHARM INC
    公开号:WO2017015449A1
    公开(公告)日:2017-01-26
    The present invention discloses compounds of Formula (I), or pharmaceutically acceptable salts, esters, or prodrugs thereof: which inhibit Respiratory Syncytial Virus (RSV). The present invention further relates to pharmaceutical compositions comprising the aforementioned compounds for administration to a subject suffering from RSV infection. The invention also relates to methods of treating an RSV infection in a subject by administering a pharmaceutical composition comprising the compounds of the present invention.
    本发明公开了化合物的结构式(I),或其药学上可接受的盐、酯或前药:这些化合物抑制呼吸道合胞病毒(RSV)。本发明还涉及包含上述化合物的药物组合物,用于治疗患有RSV感染的受试者。该发明还涉及通过给予包含本发明化合物的药物组合物来治疗受试者的RSV感染的方法。
  • HEXAHYDRODIAZEPINOQUINOLINES CARRYING A CYCLIC RADICAL
    申请人:AbbVie Deutschland GmbH & Co. KG
    公开号:US20150259343A1
    公开(公告)日:2015-09-17
    The present invention relates to tricyclic hexahydrodiazepinoquinolines carrying a cyclic substituent, to a method for producing them, to a pharmaceutical composition containing such compounds, to their use as modulators, especially agonists or partial agonists, of the 5-HT 2C receptor, their use for preparing a medicament for the prevention or treatment of conditions and disorders which respond to the modulation of 5-HT 2C receptor, to a method for preventing or treating conditions and disorders which respond to the modulation of 5-HT 2C receptor, and processes for preparing such compounds and compositions.
    本发明涉及携带环状取代基的三环六氢二氮杂喹啉类化合物,以及生产它们的方法,含有这类化合物的药物组合物,它们作为5-HT2C受体的调节剂,特别是激动剂或部分激动剂的用途,用于制备用于预防或治疗对5-HT2C受体调节产生反应的疾病和疾病的药物,用于预防或治疗对5-HT2C受体调节产生反应的疾病和疾病的方法,以及制备这类化合物和组合物的方法。
  • [EN] PYRIDOPYRIMIDINONE DERIVATIVES AS AHR ANTAGONISTS<br/>[FR] DÉRIVÉS DE PYRIDOPYRIMIDINONE UTILISÉS COMME ANTAGONISTES DE L'AHR
    申请人:SENDA BIOSCIENCES INC
    公开号:WO2021102288A1
    公开(公告)日:2021-05-27
    The present disclosure relates to compounds of formula (Ia) and pharmaceutically acceptable salts thereof, pharmaceutical compositions comprising the same, methods of preparing the same, intermediate compounds useful for preparing the same, and methods for treating or prophylaxis of diseases, in particular cancer or conditions with dysregulated immune responses or other disorders associated with aberrant AHR signaling. These compounds may also be useful in treating cancer when administered in combination with at least one additional therapy.
    本公开涉及式(Ia)化合物及其药用可接受的盐,包括该化合物的制剂、制备方法、用于制备该化合物的中间体化合物,以及治疗或预防疾病的方法,特别是癌症或与异常AHR信号传导相关的疾病或病况的方法。这些化合物在与至少一种额外疗法联合使用时,也可能有助于治疗癌症。
  • [EN] PURINE INHIBITORS OF HUMAN PHOSPHATIDYLINOSITOL 3-KINASE DELTA<br/>[FR] INHIBITEURS PURIQUES DE LA PHOSPHATIDYLINOSITOL 3-KINASE DELTA HUMAINE
    申请人:MERCK SHARP & DOHME
    公开号:WO2019119206A1
    公开(公告)日:2019-06-27
    Provided herein is compounds of formulas (Ia) and (Ib) which are PI3K-delta inhibitors, and uses for the treatment of PI3K-delta-mediated diseases such as inflammation, asthma, COPD and cancer.
    本文提供的是化合物的化学式(Ia)和(Ib),这些化合物是PI3K-delta抑制剂,用于治疗PI3K-delta介导的疾病,如炎症、哮喘、慢性阻塞性肺病和癌症。
查看更多

同类化合物

(2-三甲基甲硅烷基)-乙氧基甲基三氟硼酸钾 频哪醇(二氯甲基)硼酸酯 顺式-2-丁烯-1-硼酸频那醇酯 钾环丙基甲基三氟硼酸 钾反-1-癸烯基三氟硼酸 钾三氟(戊基)硼酸酯(1-) 钾三氟(丙基)BORANUIDE 钾三氟(1-己炔-1-基)硼酸酯(1-) 钾1-癸炔-1-基(三氟)硼酸酯(1-) 钾(E)-丙烯基-1-三氟硼酸 钾(E)-丙烯基-1-三氟硼酸 钾(2-甲氧基乙基)三氟硼酸酯 辛基硼酸频呢醇酯 辛基三氟硼酸钾 羟基二异丙基硼烷 羟基二丙基硼烷 碘甲基硼酸频哪醇酯 硼酸频那醇异丁酯 硼酸,二甲基,甲酯 硼酸,(4-溴丁基)-,二甲基酯 硼烷胺,N,1-二溴-N-(1,1-二甲基乙基)-1-甲基- 硼烷胺,1-溴-N-(1,1-二甲基乙基)-1-乙基- 硼烷,二氯(1-甲基乙烯基)- 甲氧基甲基硼酸 甲氧基甲基三氟硼酸钾 甲基硼酸频呐醇酯 甲基硼酸新戊二醇酯 甲基硼酸-d3 甲基硼酸 甲基双(二异丙基氨基)硼烷 甲基二环戊基硼酸酯 甲基二氯硼烷 甲基二己基硼酸酯 甲基二丁基硼酸酯 甲基三氟硼酸钾 甲基7-甲氧基苯并噻吩-2-羧酸酯 甲基2-(4-(4,4,5,5-四甲基-1,3,2-二氧硼杂环戊烷-2-基)环己-3-烯基)乙酸甲酯 甲基-硼酸二甲酯 环戊烷三氟硼酸钾 环戊烯-1-基硼酸 环戊氧基甲基三氟硼酸钾 环戊基硼酸频呢醇酯(含有数量不等的酸酐) 环戊基硼酸-1,3-丙二醇酯 环戊基硼酸 环庚烯-1-基硼酸 环庚基硼酸 环庚基三氟硼酸钾 环己酮-3-硼酸酯 环己烷硼酸频那醇酯 环己烯基三氟硼酸钾